Literature DB >> 30497794

Long-acting technologies for infectious diseases in LMICs.

Lelio Marmora1, Carmen Pérez Casas2, Ian Grubb3, Craig McClure3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30497794     DOI： 10.1016/S0140-6736(18)32544-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Osmolality of Excipients for Parenteral Formulation Measured by Freezing Point Depression and Vapor Pressure - A Comparative Analysis.

Authors:  Mariana Hugo Silva; Sarah P Hudson; Lidia Tajber; Matthieu Garin; Wenyu Dong; Tatsiana Khamiakova; René Holm
Journal:  Pharm Res       Date:  2022-04-22       Impact factor: 4.200

2.  Calling for policy actions to increase access to long-acting antipsychotics in low-income and middle-income countries.

Authors:  Giovanni Ostuzzi; Chiara Gastaldon; Davide Papola; Corrado Barbui
Journal:  Epidemiol Psychiatr Sci       Date:  2022-05-11       Impact factor: 7.818

3.  Long-Acting Injectable Statins-Is It Time for a Paradigm Shift?

Authors:  Lee M Tatham; Neill J Liptrott; Steve P Rannard; Andrew Owen
Journal:  Molecules       Date:  2019-07-24       Impact factor: 4.411

4.  Impact of Excipients and Seeding on the Solid-State Form Transformation of Indomethacin during Liquid Antisolvent Precipitation.

Authors:  Mariana Hugo Silva; Ajay Kumar; Benjamin K Hodnett; Lidia Tajber; René Holm; Sarah P Hudson
Journal:  Cryst Growth Des       Date:  2022-09-09       Impact factor: 4.010
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.